Member login

Temel Göstergeler


Turkish Pharmaceutical Market

Turkish Pharmaceutical Market (ex-factory prices)

The Turkish pharmaceutical market reached 24.5 billion Turkish Liras (TL) in 2017. Unit sales reached 2.2 billion units.

Source: IMS, IEIS

Generic vs. Originator Drugs

Source: IMS,IEIS

Market Share of Generic vs Originator Drugs

Source: IMS,IEIS

Imported-Local Products

Source:IMS,IEIS

Market Share - Local vs. Imports

Source:IMS,IEIS

Pharmaceutical Consumption by Therapeutic Class

Pharmaceutical Consumption in Value Terms by Therapeutical Class

Oncology represented the largest proportion by volume, accounting for 11.7% of the total market. 

Source:IMS,IEIS

Pharmaceutical Consumption in Volume Terms by Therapeutical Class

Antibiotics represented the largest proportion by volume , accounting for 11.3% of the total market.

Source:IMS,IEIS

Biotechnological Drugs

Biotechnological drugs constituted 19.5% of prescription drugs with 4.1 billion TL in 2017. The reference biotechnological pharmaceutical market, which was 3.3 billion TL in 2016, grew by 19.8% in 2017 to total 3.95 billion TL. Biosimilar drugs market increased by 53.8% and reached 190 million TL in 2017.

Biotechnological drugs reached 27.7 million units in 2017.

Source:IMS,IEIS

Foreign Trade

Pharmaceutical exports reached $898 million in 2017. 

Source:TurkStat, IEIS